UBS O'Connor’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding PNTM.WS
RCM
CC
SCM
SAMU
LP
AC
FTCM
OCAM
UBS O'Connor's PNTM.WS Position: Q1 2022 in Review
UBS O'Connor sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q1 2022, closing a stake of 252,838 shares — an estimated $225K sold.
UBS O'Connor first reported a position in PNTM.WS in Q1 2021 and held it in 4 quarters. The position peaked at $259K in Q2 2021. 67 funds tracked by Wall St. Rank hold PNTM.WS as of Q1 2022.
- UBS O'Connor reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
- UBS O'Connor sold 252,838 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $225K.
- UBS O'Connor first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 4 quarters.
- UBS O'Connor's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $259K in Q2 2021.
- 67 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.
Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.